Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life

Lost in Translation: Evaluation of Subcutaneous Interferon-β Treatment for SARS-CoV-2 Infection in Real Life

Despite in vitro activity of interferon-β (IFN-β) against SARS-CoV-2 infection, its clinical efficacy remains controversial. We evaluated the impact of IFN-β treatment in a cohort of 3590 patients hospitalized with COVID-19 during March–April 2020. The primary endpoint was a composed variable of adm...

Full description

Bibliographic Details
Main Authors: José L. Casado, Pilar Vizcarra, José M. Del Rey, María Cruz Soriano, Mario Rodriguez-Dominguez, Luis Manzano, Julio Acero, Carmen Palomar-Fernandez, Alejandro Vallejo, on behalf of the COVID-19 IRYCIS Team
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Journal of Clinical Medicine
Subjects:
SARS-CoV-2
COVID-19
interferon-beta
real life
propensity score
Online Access:https://www.mdpi.com/2077-0383/11/23/6952

Internet

https://www.mdpi.com/2077-0383/11/23/6952

Similar Items